Long-term monitoring of gait in Parkinson's disease

被引:142
|
作者
Moore, Steven T.
MacDougall, Hamish G.
Gracies, Jean-Michel
Cohen, Helen S.
Ondo, William G.
机构
[1] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[2] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
关键词
stride length; levodopa; parkinsonian; locomotion; accelerometer;
D O I
10.1016/j.gaitpost.2006.09.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A new system for long-term monitoring of gait in Parkinson's disease (PD) has been developed and validated. The characteristics of every stride taken over 10-h epochs were acquired using a lightweight ankle-mounted sensor array that transmitted data wirelessly to a small pocket PC at a rate of 100 Hz. Stride was calculated from the vertical linear acceleration and pitch angular velocity of the leg with an accuracy of 5 cm. Results from PD patients (5) demonstrate the effectiveness of long-term monitoring of gait in a natural environment. The small, variable stride length characteristic of Parkinsonian gait, and fluctuations of efficacy associated with levodopa therapy, such as delayed onset, wearing off, and the 'off/on' effect, could reliably be detected from long-term changes in stride length. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 50 条
  • [31] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
    Stocchi, F
    Vacca, L
    De Pandis, MF
    Barbato, L
    Valente, M
    Ruggieri, S
    NEUROLOGICAL SCIENCES, 2001, 22 (01) : 93 - 94
  • [32] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
    F. Stocchi
    L. Vacca
    M. F. De Pandis
    L. Barbato
    M. Valente
    S. Ruggieri
    Neurological Sciences, 2001, 22 : 93 - 94
  • [33] Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease
    Busk, Karin
    Nyholm, Dag
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (08) : 1000 - 1001
  • [34] Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease
    Nyholm, D.
    Klangemo, K.
    Johansson, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (08) : 1079 - 1085
  • [35] Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia
    Fabbri, Margherita
    Zibetti, Maurizio
    Calandra-Buonaura, Giovanna
    Contin, Manuela
    Sambati, Luisa
    Mohamed, Susan
    Romagnolo, Alberto
    Berchialla, Paola
    Imbalzano, Gabriele
    Giannini, Giulia
    Rizzone, Mario G.
    Artusi, Carlo Alberto
    Cortelli, Pietro
    Lopiano, Leonardo
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (08): : 930 - 939
  • [36] Selegiline as the primary treatment of Parkinson's disease - A long-term double-blind study
    Myllyla, VV
    Sotaniemi, KA
    Hakulinen, P
    MakiIkola, O
    Heinonen, EH
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (04): : 211 - 218
  • [37] Replacement of Dopaminergic Medication with Subthalamic Nucleus Stimulation in Parkinson's Disease: Long-Term Observation
    Romito, Luigi M.
    Contarino, Maria Fiorella
    Vanacore, Nicola
    Bentivoglio, Anna Rita
    Scerrati, Massimo
    Albanese, Alberto
    MOVEMENT DISORDERS, 2009, 24 (04) : 557 - 563
  • [38] Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease
    Mestre, Tiago A.
    Sidiropoulos, Christos
    Hamani, Clement
    Poon, Yu-Yan
    Lozano, Andres M.
    Lang, Anthony E.
    Moro, Elena
    MOVEMENT DISORDERS, 2016, 31 (10) : 1570 - 1574
  • [39] Doorway-provoked freezing of gait in Parkinson's disease
    Cowie, Dorothy
    Limousin, Patricia
    Peters, Amy
    Hariz, Marwan
    Day, Brian L.
    MOVEMENT DISORDERS, 2012, 27 (04) : 492 - 499
  • [40] A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
    Kondo, Tomoyoshi
    Mizuno, Yoshikuni
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (02) : 41 - 46